Global Markets
-
Takaichi Win Propels Nikkei 225 to Record Peaks
Japan’s Prime Minister Takaichi’s party achieved a supermajority, boosting investor confidence reflected in soaring stocks and a strengthening yen. U.S. markets saw a tech-driven rally, with the Dow Jones surpassing 50,000. European markets showed resilience, exemplified by UniCredit’s record profits. However, the UK faces political scrutiny. Major tech valuations collectively dropped over $1 trillion, while unsealed Epstein documents revealed tech figure connections. Hong Kong media tycoon Jimmy Lai received a 20-year sentence. The private credit market faces AI-driven uncertainties.
-
Powell’s Remarks Steal Spotlight as Fed Holds Rates Steady
The Federal Reserve held interest rates steady, but attention focused on Fed Chair Powell’s defense of his presence at a crucial legal proceeding involving Fed Governor Lisa Cook, warning his successor against political entanglement. Meanwhile, UK PM Starmer visited China, signaling efforts to deepen ties, with early signs of cooperation. Corporate earnings from Meta, Microsoft, and Tesla showed mixed investor reactions despite exceeding expectations. The S&P 500 neared 7,000, the dollar strengthened, and gold prices hit new highs. European banks and pharma companies also reported positive results.
-
Steady Q4 Gains for U.S. Institutional Investors as Global Markets Show Resilience
Northern Trust’s Q4 analysis shows U.S. institutional investors achieved consistent gains across global markets. This resilience, despite economic uncertainties, stems from a balanced inflation outlook, strong tech sector performance driven by innovation like AI, and recovery in emerging markets. Investors are increasingly favoring alternative assets for diversification. The quarter’s positive trajectory indicates well-structured portfolios are positioned for future growth and risk mitigation.
-
A Conversation with Eli Lilly CEO Dave Ricks: Navigating the Global Future of Healthcare
The latest episode of T. Rowe Price’s “The Angle” podcast features a discussion between Eric Veiel and Eli Lilly CEO Dave Ricks on chronic disease management, leadership, and global healthcare challenges. Ricks provides insights into healthcare’s future, particularly regarding innovations in areas like diabetes, cancer, Alzheimer’s, and weight loss drugs. The podcast, part of a C-suite series, aims to offer dynamic perspectives on market trends and connects macroeconomic forces with corporate strategy. “The Angle” is one of two podcasts by T. Rowe Price, which manages $1.79 trillion in assets.
